A detailed history of Belmont Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Belmont Capital, LLC holds 3,058 shares of NVS stock, worth $301,060. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,058
Previous 3,058 -0.0%
Holding current value
$301,060
Previous $325,000 8.0%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $263,823 - $292,787
2,785 Added 1020.15%
3,058 $311,000
Q2 2023

Aug 10, 2023

BUY
$92.52 - $104.91 $12,212 - $13,848
132 Added 93.62%
273 $27,000
Q3 2022

Oct 18, 2022

BUY
$74.61 - $87.26 $10,520 - $12,303
141 New
141 $11,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Belmont Capital, LLC Portfolio

Follow Belmont Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belmont Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belmont Capital, LLC with notifications on news.